Your browser doesn't support javascript.
loading
Multi-omic machine learning predictor of breast cancer therapy response.
Sammut, Stephen-John; Crispin-Ortuzar, Mireia; Chin, Suet-Feung; Provenzano, Elena; Bardwell, Helen A; Ma, Wenxin; Cope, Wei; Dariush, Ali; Dawson, Sarah-Jane; Abraham, Jean E; Dunn, Janet; Hiller, Louise; Thomas, Jeremy; Cameron, David A; Bartlett, John M S; Hayward, Larry; Pharoah, Paul D; Markowetz, Florian; Rueda, Oscar M; Earl, Helena M; Caldas, Carlos.
Affiliation
  • Sammut SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Crispin-Ortuzar M; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Chin SF; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Provenzano E; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Bardwell HA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Ma W; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Cope W; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Dariush A; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Dawson SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Abraham JE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Dunn J; Institute of Astronomy, University of Cambridge, Cambridge, UK.
  • Hiller L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Thomas J; Centre of Cancer Research and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Cameron DA; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Bartlett JMS; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Hayward L; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Pharoah PD; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Markowetz F; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
  • Rueda OM; Q2 Laboratory Solutions, Livingston, UK.
  • Earl HM; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
  • Caldas C; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.
Nature ; 601(7894): 623-629, 2022 01.
Article in En | MEDLINE | ID: mdl-34875674
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Ecosystem Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Ecosystem Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: United kingdom